What is ERA?
Endometrial Receptivity Analysis (ERA) is a specialized diagnostic test that evaluates the receptivity of the endometrium (uterine lining) to embryo implantation. This precise analysis helps determine the most favorable window for embryo transfer, ensuring synchronization between the embryo’s developmental stage and the receptive state of the uterus.
Clinical Indications:
ERA is recommended for individuals facing challenges with implantation failure or recurrent pregnancy loss. Clinical indications include:
- Unexplained infertility
- Repeated implantation failure during IVF cycles
- Recurrent pregnancy loss
- Shifted or displaced implantation window
Potential Benefits:
- Personalized Timing: ERA identifies the specific window of optimal endometrial receptivity for each individual, enabling precise embryo transfer timing.
- Increased Implantation Potential: By aligning embryo transfer with the receptive state of the endometrium, ERA enhances the chances of successful implantation.
- Targeted Treatment: Results from ERA guide fertility specialists in tailoring treatment protocols for more effective and efficient outcomes.
How ERA Is Done:
- Endometrial Biopsy: A small tissue sample is taken from the endometrium, typically during a mock cycle or an actual cycle preceding the planned IVF cycle.
- RNA Analysis: The collected sample undergoes RNA analysis to assess the expression of specific genes associated with endometrial receptivity.
- Customized Timing Recommendation: Based on the RNA analysis, a personalized report is generated, indicating the optimal window for embryo transfer.
At Alhaya Fertility Centre, our dedicated team utilizes ERA as a valuable tool in addressing the complexities of fertility. We prioritize precision and personalized care to enhance your chances of a successful pregnancy. ERA represents another step forward in our commitment to advancing reproductive science and making your journey to parenthood as seamless as possible.